Reference data : LOINC code

Filter


Clear filter

Results
108,248 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
93418-2 (8;8)(q13;q21)(HEY1,NCOA2) fusion transcript PrThr Tiss Pt Ord Molgen &nbsp; ACTIVE (8;8)(q13;q21)(HEY1,NCOA2) fusion transcript [Presence] in Tissue by Molecular genetics method &nbsp; ADD DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MOLPATH &nbsp; 93418-2 &nbsp; Molgen &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 (8;8)(HEY1,NCOA2) Tiss Ql &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; (8;8)(HEY1,NCOA2); DNA; gene fusion; gene translocation; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; Tissue; Tissue, unspecified; translocation 2.67 2.67 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
98203-3 (Diffusion capacity/Alveolar volume)/predicted RelInvVI Respiratory system Pt Qn &nbsp; &nbsp; ACTIVE (Diffusion capacity/Alveolar volume)/predicted &nbsp; ADD DefinitionDescription &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PULM &nbsp; 98203-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 (Diff cap/Alv vol)/predicted &nbsp; &nbsp; &nbsp; N &nbsp; (Diff cap; (Diff cap/Alv vol)/predicted; ALV; Breathing; Diff cap; DL; Lung; Lungs; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS; Vol 2.71 2.71 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; &nbsp; 0
32406-1 Color^1M post birth Fcn ^Patient Pt Ord Apgar &nbsp; ACTIVE 1 minute Apgar Color &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; NEONAT &nbsp; 32406-1 &nbsp; Apgar &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1M Apgar Color &nbsp; &nbsp; &nbsp; N &nbsp; After; Appearance; Colour; Function; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; QL; Qual; Qualitative; Random; Screen 2.36 2.07 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
32407-9 Heart rate^1M post birth Fcn ^Patient Pt Ord Apgar &nbsp; ACTIVE 1 minute Apgar Heart rate &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; NEONAT &nbsp; 32407-9 &nbsp; Apgar &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1M Apgar Heart rate &nbsp; &nbsp; &nbsp; N &nbsp; After; Function; Gyn; Gynecology; Heart beat; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; Pulse; QL; Qual; Qualitative; Random; Screen 2.36 2.07 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
32408-7 Muscle tone^1M post birth Fcn ^Patient Pt Ord Apgar &nbsp; ACTIVE 1 minute Apgar Muscle tone &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; NEONAT &nbsp; 32408-7 &nbsp; Apgar &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1M Apgar Muscle tone &nbsp; &nbsp; &nbsp; N &nbsp; Activity; After; Function; Gyn; Gynecology; Musc; Muscl; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; QL; Qual; Qualitative; Random; Screen 2.36 2.07 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
32409-5 Reflex irritability^1M post birth Fcn ^Patient Pt Ord Apgar &nbsp; ACTIVE 1 minute Apgar Reflex irritability &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; NEONAT &nbsp; 32409-5 &nbsp; Apgar &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1M Apgar Reflex irritability &nbsp; &nbsp; &nbsp; N &nbsp; After; Function; Grimace; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; QL; Qual; Qualitative; Random; Screen 2.36 2.07 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
32410-3 Respiratory effort^1M post birth Fcn ^Patient Pt Ord Apgar &nbsp; ACTIVE 1 minute Apgar Respiratory effort &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; NEONAT &nbsp; 32410-3 &nbsp; Apgar &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1M Apgar Resp effort &nbsp; &nbsp; &nbsp; N &nbsp; After; Function; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; Ordinal; p birth; Point in time; PST; QL; Qual; Qualitative; Random; Resp effort; Screen 2.36 2.07 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
9272-6 Score^1M post birth Fcn ^Patient Pt Qn Apgar &nbsp; ACTIVE 1 minute Apgar Score &nbsp; MIN DefinitionDescription &nbsp; &nbsp; score &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; NEONAT &nbsp; 9272-6 &nbsp; Apgar &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1M Apgar Score &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; After; Function; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; p birth; Point in time; PST; QNT; Quan; Quant; Quantitative; Random 2.73 1.0i &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {score} &nbsp; &nbsp; We made an administrative decision to define the total scores from arious survey instruments as Quantitative rather than ordinal. There is no intention to change the existing meaning 0
48334-7 Apgar panel^1M post birth - ^Patient Pt - Apgar &nbsp; ACTIVE 1 minute Apgar panel &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.NEONAT &nbsp; 48334-7 &nbsp; Apgar &nbsp; &nbsp; Order &nbsp; &nbsp; &nbsp; 0 1M Apgar Pnl &nbsp; &nbsp; &nbsp; N &nbsp; After; Apgar Pnl; Gyn; Gynecology; NEONAT; OB; ObGyn; Obstetrics; p birth; Pan; PANEL.NEONAT; Panl; Pnl; Point in time; PST; Random 2.63 2.21 &nbsp; Panel &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
83196-6 1 step (curb) - functional ability during 3D assessment period Find ^Patient 3D Ord CMS Assessment &nbsp; ACTIVE 1 step (curb) - functional ability during 3 day assessment period [CMS Assessment] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CMS &nbsp; 83196-6 &nbsp; CMS Assessment &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1 step curb ability; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; i; Ordinal; Ql; Qual; Qualitative; Screen; Survey 2.64 2.61 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
89421-2 1 step (curb) - functional ability Find ^Patient RptPeriod Ord CMS Assessment &nbsp; ACTIVE 1 step (curb) - functional ability during assessment period [CMS Assessment] &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CMS &nbsp; 89421-2 &nbsp; CMS Assessment &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; i; IADL; Ordinal; QL; Qual; Qualitative; Report period; Screen; Survey 2.77 2.64 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.77: TIME_ASPCT: Decision by CMS to update the Timing to RptPeriod from Pt for all CMS Assessments; 0
83195-8 1 step (curb) - functional goal recorded during 3D assessment period Find ^Patient 3D Ord CMS Assessment &nbsp; ACTIVE 1 step (curb) - functional goal during 3 day assessment period [CMS Assessment] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CMS &nbsp; 83195-8 &nbsp; CMS Assessment &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 1 step curb goal; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; i; Ordinal; Ql; Qual; Qualitative; Screen; Survey 2.64 2.61 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
80628-1 1,1'-Sulfonylbis-2-Methylthioethane MCnc Urine Pt Qn &nbsp; &nbsp; ACTIVE 1,1'-Sulfonylbis-2-Methylthioethane [Mass/volume] in Urine &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ug/L &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 80628-1 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 SBMTE Ur-mCnc &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOXICOLOGY; Drugs; Esoteric; i; II; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SBMTE; Sulfur mustard gas metabolite; UA; UR; Urn 2.56 2.56 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/L &nbsp; &nbsp; &nbsp; 0
38624-3 1,1,2-Trichloroethane MCnc Air Pt Qn &nbsp; &nbsp; ACTIVE 1,1,2-Trichloroethane [Mass/volume] in Air &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 38624-3 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1,1,2TCE Air-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; 1,1,1-TCE; 1,1,2TCE; 1,1,2-TCE; Aerothene tt; Alpha trichloroethane; Beta trichloroethane; Beta-T; C2H3Cl3; Chlorothene; Chlorothene NU; Chlorothene VG; DRUG/TOXICOLOGY; Drugs; i; II; Level; Mass concentration; Methyl chloroform; Methylchloroform; Methyltrichloromethane; Point in time; QNT; Quan; Quant; Quantitative; Random; TCE; Tri-ethane; Vinyl trichloride 2.34 2.14 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
38334-9 1,1,2-Trichloroethane MCnc Water Pt Qn &nbsp; &nbsp; ACTIVE 1,1,2-Trichloroethane [Mass/volume] in Water &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 38334-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1,1,2TCE Wat-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; 1,1,1-TCE; 1,1,2TCE; 1,1,2-TCE; Aerothene tt; Alpha trichloroethane; Beta trichloroethane; Beta-T; C2H3Cl3; Chlorothene; Chlorothene NU; Chlorothene VG; DRUG/TOXICOLOGY; Drugs; i; II; Level; Mass concentration; Methyl chloroform; Methylchloroform; Methyltrichloromethane; Point in time; QNT; Quan; Quant; Quantitative; Random; TCE; Tri-ethane; Vinyl trichloride; Wat 2.34 2.13 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
38699-5 1,1-Dichloroethane MCnc Air Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dichloroethane [Mass/volume] in Air &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 38699-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 1,1-DCA Air-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; 1,1-DCA; 1,1-dichlorethane; DCA; DRUG/TOXICOLOGY; Drugs; Ethylidene chloride; Ethylidene dichloride; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random 2.34 2.14 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
38735-7 1,1-Dichloroethylene MCnc Air Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dichloroethylene [Mass/volume] in Air &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 38735-7 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1,1-DCE Air-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; 1,1-DCE; 1,1-Dichloroethene; Asym-dichloro-ethylene; DCE; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vinylidene; Vinylidine 2.34 2.14 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
38292-9 1,1-Dichloroethylene MCnc Water Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dichloroethylene [Mass/volume] in Water &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; DRUG/TOX &nbsp; 38292-9 &nbsp; &nbsp; &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 1,1-DCE Wat-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; 1,1-DCE; 1,1-Dichloroethene; Asym-dichloro-ethylene; DCE; DRUG/TOXICOLOGY; Drugs; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vinylidene; Vinylidine; Wat 2.34 2.13 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
74622-2 1,1-Dimethoxy-(9Z)octadecene MCnt Fibroblasts Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/mass] in Fibroblast &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ug/mg protein &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 74622-2 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 DMA 18:1 Fib-mCnt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Fib; Fibr; i; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random 2.48 2.48 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/mg{protein} &nbsp; &nbsp; &nbsp; 0
104684-6 1,1-Dimethoxy-(9Z)octadecene MCnc Bld.dot Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/volume] in DBS &nbsp; ADD DefinitionDescription &nbsp; &nbsp; ug/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 104684-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 DMA 18:1 DBS-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Blood; Chemistry; DBS; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Dried blood spot; Filter paper; FP; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood 2.78 2.78 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/mL &nbsp; &nbsp; &nbsp; 0
104679-6 1,1-Dimethoxy-(9Z)octadecene MCnc RBC Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Mass/volume] in Red Blood Cells &nbsp; ADD DefinitionDescription &nbsp; &nbsp; ug/mL &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 104679-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 DMA 18:1 RBC-mCnc &nbsp; &nbsp; &nbsp; N &nbsp; Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Erythrocytes; i; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles 2.78 2.78 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/mL &nbsp; &nbsp; &nbsp; 0
74623-0 1,1-Dimethoxy-(9Z)octadecene SCnt RBC Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1) [Moles/mass] in Red Blood Cells &nbsp; MIN DefinitionDescription &nbsp; &nbsp; nmol/100mg Hb &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 74623-0 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 DMA 18:1 RBC-sCnt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Erythrocytes; i; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Substance content 2.66 2.48 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; nmol/(100.mg){Hb} &nbsp; &nbsp; &nbsp; 0
74620-6 1,1-Dimethoxy-(9Z)octadecene/oleate MRto Fibroblasts Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Mass Ratio] in Fibroblast &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ratio &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 74620-6 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 DMA 18:1/Oleate Fib &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; C18:1w9; Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Fib; Fibr; i; Mass concentration ratio; Mass ratio; MCRto; Oleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random 2.48 2.48 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {ratio} &nbsp; &nbsp; &nbsp; 0
74621-4 1,1-Dimethoxy-(9Z)octadecene/oleate SRto RBC Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dimethoxy-(9Z)octadecene (DMA 18:1)/Oleate (C18:1w9) [Molar ratio] in Red Blood Cells &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ratio &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 74621-4 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 DMA 18:1/Oleate RBC-sRto &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; C18:1w9; Chemistry; dimethyl acetal oleic; DMA 18:1; DMA C18:1; Erythrocytes; i; Oleic acid; Point in time; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Scrto; Substance concentration ratio; Substance ratio 2.48 2.48 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; {ratio} &nbsp; &nbsp; &nbsp; 0
74626-3 1,1-Dimethoxyhexadecane MCnt Fibroblasts Pt Qn &nbsp; &nbsp; ACTIVE 1,1-Dimethoxyhexadecane (DMA 16:0) [Mass/mass] in Fibroblast &nbsp; MIN DefinitionDescription &nbsp; &nbsp; ug/mg protein &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CHEM &nbsp; 74626-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 DMA 16:0 Fib-mCnt &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Chemistry; dimethyl acetal palmitic; DMA 16:0; DMA C16:0; Fib; Fibr; i; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random 2.48 2.48 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ug/mg{protein} &nbsp; &nbsp; &nbsp; 0
108,248 results found